Ziprasidone Capsule
Product Images NDC 55111-256

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Ziprasidone (NDC 55111-256). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton1 (Carton1)

Carton1 (Carton1)
Each capsule of this medication contains 20 mg of Ziprasidone hydrochloride, as specified in the prescribing information. The package is not child-resistant and the blisters should be kept in the carton. Storage is recommended at 20°-25°C (68°77°F), but permitted excursions go up to 15°-30°C (59°-86°F). The medication comes in a unit-dose packaging with 100 capsules (10 blister cards containing 10 capsules each). For more information, patients should consult the Patient Information Sheet available on the manufacturer's website. The medication is manufactured by Dr. Reddy’s Laboratories Limited located in India.*
FDA Label Image

Carton2 (Carton2)

Carton2 (Carton2)
Each capsule of the medication Ziprasidone hydrochloride USP contains 40 mg of ziprasidone. The usual dosage should be referred as per the prescribing information provided. The package is not child-resistant and must be stored at a temperature between 20°C to 25°C with excursions permitted to 15°C to 30°C. The blisters must be retained in the carton until use. The unit-dose package contains 100 capsules divided into 10 blister cards with each blister card holding 10 capsules. The lot number and Bxp information are also available. This is a prescription medicine, and the patient information sheet must be provided by the pharmacist. More information can be obtained from the Dr.Reddys' official website. The manufacturer's name is Dr. Reddy's Laboratories Limited from Bachupally, India.*
FDA Label Image

Carton3 (Carton3)

Carton3 (Carton3)
The text provides information regarding the contents, dosage, storage, and packaging of Ziprasidone hydrochloride capsules. It contains 100 capsules of 60mg each, not child-resistant, and should be stored within the temperature range of 20°-25°C. The text also includes manufacturing and dispensing information for pharmacists. Therefore, it can be used as a reference for clinical professionals to ensure the safe handling, storage, and dispensing of the medication.*
FDA Label Image

Carton4 (Carton4)

Carton4 (Carton4)
Each capsule contains 80 mg of ziprasidone hydrochloride. The usual dosage and prescribing information are not available. The unit-dose package is not child-resistant. The capsules should be stored at room temperature, and blisters should be kept in the carton until use. The box contains 100 capsules in unit-dose blister cards, and the NDC number is 55111-259-78. It is a prescription drug manufactured by Dr. Reddy's Laboratories Ltd. The patient information sheet is available on the official website.*
FDA Label Image

Container1 (Container1)

FDA Label Image

Container2 (Container2)

FDA Label Image

Container3 (Container3)

Container3 (Container3)
This is a medication label for the prescription drug Risperidone Capsules, USP. It contains information such as the National Drug Code (NDC), the number of capsules in the bottle (60), the dosage strength (60mg), and instructions for dispensing the Patient Information Sheet to each patient. The label also includes some alphanumeric codes and a QR code for accessing the Patient Information Sheet electronically.*
FDA Label Image

Container4 (Container4)

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.